Literature DB >> 12847440

Prevalence of hepatitis viral infection in dental patients with impacted teeth or jaw deformities.

Yutaka Takata1, Kazuhiro Tominaga, Toru Naito, Hideo Kurokawa, Kazuo Sonoki, Daisuke Goto, Masanori Wakisaka, Jinichi Fukuda, Makoto Yokota, Tetsu Takahashi.   

Abstract

OBJECTIVE: The prevalence of infection with hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis G virus (HGV), and transfusion-transmitted viruses (TTV) was evaluated in patients with impacted teeth or jaw deformities. STUDY
DESIGN: Of 486 patients, 268 had serum samples available for retrospective TTV DNA and HGV RNA assays. In addition, the sera of 404 patients were assayed for HB surface antigen and the sera of 340 were assayed for HCV antibody.
RESULTS: HGV RNA was detected in 3 of 268 patients (1.1%), and TTV DNA was detected in 60 of 268 (22.4%). Of 404 patients, 3 had HB surface antigens (0.7%). Furthermore, 13 of 340 were HCV-seropositive (3.8%). The rate of infection was similar between patients with impacted teeth and those with jaw deformities, respectively, as follows: 1.1% versus 0%, respectively, for HBV prevalence; 4.1% versus 3.2% for HCV prevalence; 1.8% versus 0% for HGV prevalence; and 22.9% versus 21.4% for TTV prevalence.
CONCLUSIONS: Universal precautions to prevent hepatitis and TTV infection during oral surgical procedures are important.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847440     DOI: 10.1016/s1079-2104(03)00094-5

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  1 in total

1.  The Effectiveness of Pre-Operative Screening Tests in Determining Viral Infections in Patients Undergoing Oral and Maxillofacial Surgery.

Authors:  Shintaro Sukegawa; Yuka Sukegawa; Kazuaki Hasegawa; Sawako Ono; Tomoya Nakamura; Ai Fujimura; Ayaka Fujisawa; Keisuke Nakano; Kiyofumi Takabatake; Hotaka Kawai; Yumika Mukainaka; Hitoshi Nagatsuka; Yoshihiko Furuki
Journal:  Healthcare (Basel)       Date:  2022-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.